As of 4:00pm ET
| -0.11 / -3.74%|
The 6 analysts offering 12-month price forecasts for Aptose Biosciences Inc have a median target of 7.00, with a high estimate of 8.50 and a low estimate of 6.00. The median estimate represents a +147.35% increase from the last price of 2.83.
The current consensus among 6 polled investment analysts is to Buy stock in Aptose Biosciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.